Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway

The editor has retracted this article [1] because Figures 2 and 4 contain duplicated and modified figures from [2–4]. The data reported in this article are therefore unreliable.

Bibliographic Details
Main Authors: Xiaoyan Ding, Wei Sun, Jinglong Chen
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Cancer Cell International
Online Access:https://doi.org/10.1186/s12935-019-1083-8
_version_ 1818364012415418368
author Xiaoyan Ding
Wei Sun
Jinglong Chen
author_facet Xiaoyan Ding
Wei Sun
Jinglong Chen
author_sort Xiaoyan Ding
collection DOAJ
description The editor has retracted this article [1] because Figures 2 and 4 contain duplicated and modified figures from [2–4]. The data reported in this article are therefore unreliable.
first_indexed 2024-12-13T21:57:36Z
format Article
id doaj.art-996f4ff7dc084c8f859daf03841458f1
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-13T21:57:36Z
publishDate 2019-12-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-996f4ff7dc084c8f859daf03841458f12022-12-21T23:30:05ZengBMCCancer Cell International1475-28672019-12-011911110.1186/s12935-019-1083-8Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathwayXiaoyan Ding0Wei Sun1Jinglong Chen2Cancer Center, Beijing Ditan Hospital, Capital Medical UniversityCancer Center, Beijing Ditan Hospital, Capital Medical UniversityCancer Center, Beijing Ditan Hospital, Capital Medical UniversityThe editor has retracted this article [1] because Figures 2 and 4 contain duplicated and modified figures from [2–4]. The data reported in this article are therefore unreliable.https://doi.org/10.1186/s12935-019-1083-8
spellingShingle Xiaoyan Ding
Wei Sun
Jinglong Chen
Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
Cancer Cell International
title Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title_full Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title_fullStr Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title_full_unstemmed Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title_short Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title_sort retraction note to il 2 augments the sorafenib induced apoptosis in liver cancer by promoting mitochondrial fission and activating the jnk taz pathway
url https://doi.org/10.1186/s12935-019-1083-8
work_keys_str_mv AT xiaoyanding retractionnotetoil2augmentsthesorafenibinducedapoptosisinlivercancerbypromotingmitochondrialfissionandactivatingthejnktazpathway
AT weisun retractionnotetoil2augmentsthesorafenibinducedapoptosisinlivercancerbypromotingmitochondrialfissionandactivatingthejnktazpathway
AT jinglongchen retractionnotetoil2augmentsthesorafenibinducedapoptosisinlivercancerbypromotingmitochondrialfissionandactivatingthejnktazpathway